Horizon Therapeutics Public Limited Company focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe in...

Read More

HZNP Performance At-A-Glance

RISK EFFICIENCY

0.41

Horizon Pharma PLC's risk efficiency is 0.41, which is OK. By comparison, the S&P500 is -0.39.

Increasing quickly  over the past 4 weeks.

DSCORE

4.06%

Horizon Pharma PLC's dScore is 4.06% , which is more volatile than the S&P500 (2.79%).

GROWTH

19.74%

Horizon Pharma PLC has grown by 19.74% over the past year.  By comparison, the S&P500 has lost -7.38%.